• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Does the RAAS play a role in loss of taste and smell during COVID-19 infections?

作者信息

Luchiari Heloise R, Giordano Ricardo J, Sidman Richard L, Pasqualini Renata, Arap Wadih

机构信息

Department of Biochemistry, Institute of Chemistry, University of São Paulo, São Paulo, SP, Brazil.

Department of Neurology, Harvard Medical School, Boston, MA, USA.

出版信息

Pharmacogenomics J. 2021 Apr;21(2):109-115. doi: 10.1038/s41397-020-00202-8. Epub 2020 Dec 15.

DOI:10.1038/s41397-020-00202-8
PMID:33323946
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7737200/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63e1/7997803/1e47a589e9d1/41397_2020_202_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63e1/7997803/8bce4dc2caa8/41397_2020_202_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63e1/7997803/1e47a589e9d1/41397_2020_202_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63e1/7997803/8bce4dc2caa8/41397_2020_202_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63e1/7997803/1e47a589e9d1/41397_2020_202_Fig2_HTML.jpg

相似文献

1
Does the RAAS play a role in loss of taste and smell during COVID-19 infections?肾素-血管紧张素-醛固酮系统（RAAS）在新冠病毒感染期间味觉和嗅觉丧失中起作用吗？
Pharmacogenomics J. 2021 Apr;21(2):109-115. doi: 10.1038/s41397-020-00202-8. Epub 2020 Dec 15.
2
SARS-CoV-2 and hypertension.SARS-CoV-2 与高血压。
Physiol Rep. 2021 Jun;9(11):e14800. doi: 10.14814/phy2.14800.
3
COVID-19 pathophysiology may be driven by an imbalance in the renin-angiotensin-aldosterone system.COVID-19 的病理生理学可能是由肾素-血管紧张素-醛固酮系统失衡驱动的。
Nat Commun. 2021 Apr 23;12(1):2417. doi: 10.1038/s41467-021-22713-z.
4
Increased complications of COVID-19 in people with cardiovascular disease: Role of the renin-angiotensin-aldosterone system (RAAS) dysregulation.心血管疾病患者 COVID-19 并发症增加：肾素-血管紧张素-醛固酮系统（RAAS）失调的作用。
Chem Biol Interact. 2022 Jan 5;351:109738. doi: 10.1016/j.cbi.2021.109738. Epub 2021 Nov 3.
5
Loss of Smell and Taste in 2013 European Patients With Mild to Moderate COVID-19.2013年欧洲轻至中度新冠肺炎患者的嗅觉和味觉丧失情况
Ann Intern Med. 2020 Oct 20;173(8):672-675. doi: 10.7326/M20-2428. Epub 2020 May 26.
6
Characteristics of COVID-19 smell and taste dysfunction in hospitalized patients.COVID-19 嗅觉和味觉障碍患者的特征。
Am J Otolaryngol. 2021 Nov-Dec;42(6):103068. doi: 10.1016/j.amjoto.2021.103068. Epub 2021 Apr 19.
7
Decrease and Recovery of Olfactory and Gustatory Function in a Case of SARS-CoV-2 Infection.SARS-CoV-2 感染病例中嗅觉和味觉功能的减退与恢复。
ORL J Otorhinolaryngol Relat Spec. 2021;83(2):130-134. doi: 10.1159/000512875. Epub 2020 Dec 2.
8
Smell and taste disorders in COVID-19: From pathogenesis to clinical features and outcomes.新型冠状病毒肺炎相关的嗅觉和味觉障碍：从发病机制到临床特征和结局。
Neurosci Lett. 2021 Mar 23;748:135694. doi: 10.1016/j.neulet.2021.135694. Epub 2021 Feb 15.
9
RAAS Blockade and COVID-19: Mechanistic Modeling of Mas and AT1 Receptor Occupancy as Indicators of Pro-Inflammatory and Anti-Inflammatory Balance.RAAS 阻断与 COVID-19：Mas 和 AT1 受体占有率的机械建模作为促炎和抗炎平衡的指标。
Clin Pharmacol Ther. 2021 Apr;109(4):1092-1103. doi: 10.1002/cpt.2177. Epub 2021 Mar 10.
10
Acute loss of smell and taste among patients with symptoms compatible with COVID-19.出现与COVID-19相符症状的患者中嗅觉和味觉急性丧失。
Dan Med J. 2020 Aug 6;67(9):A05200370.

引用本文的文献

1
Olfactory Dysfunction as a Marker for Essential Hypertension in a Drug-Naive Adult Population: A Hospital-Based Study.嗅觉功能障碍作为未服用药物的成年人群原发性高血压的标志物：一项基于医院的研究。
Cureus. 2023 Jul 15;15(7):e41920. doi: 10.7759/cureus.41920. eCollection 2023 Jul.
2
The immune mechanism of the nasal epithelium in COVID-19-related olfactory dysfunction.COVID-19 相关嗅觉功能障碍中鼻上皮的免疫机制。
Front Immunol. 2023 Jul 17;14:1045009. doi: 10.3389/fimmu.2023.1045009. eCollection 2023.
3
Olfactory dysfunction in COVID-19: new insights into the underlying mechanisms.

本文引用的文献

1
Self-Reported Symptoms of COVID-19, Including Symptoms Most Predictive of SARS-CoV-2 Infection, Are Heritable.自我报告的 COVID-19 症状，包括最能预测 SARS-CoV-2 感染的症状，是可遗传的。
Twin Res Hum Genet. 2020 Dec;23(6):316-321. doi: 10.1017/thg.2020.85.
2
Establishment of an African green monkey model for COVID-19 and protection against re-infection.建立用于 COVID-19 的非洲绿猴模型并预防再感染。
Nat Immunol. 2021 Jan;22(1):86-98. doi: 10.1038/s41590-020-00835-8. Epub 2020 Nov 24.
3
The major genetic risk factor for severe COVID-19 is inherited from Neanderthals.
新冠病毒感染导致的嗅觉功能障碍：潜在机制的新认识。
Trends Neurosci. 2023 Jan;46(1):75-90. doi: 10.1016/j.tins.2022.11.003. Epub 2022 Nov 16.
4
The Prevalence and Implications of Olfactory/Gustatory Dysfunctions among Adult COVID-19 Patients: A Retrospective Cohort Multiethnic Populations Study.成年新冠病毒肺炎患者嗅觉/味觉功能障碍的患病率及其影响：一项回顾性队列多民族人群研究
Trop Med Infect Dis. 2022 Jun 23;7(7):115. doi: 10.3390/tropicalmed7070115.
5
The Prevalence and Pathophysiology of Chemical Sense Disorder Caused by the Novel Coronavirus.新型冠状病毒引起的化学感觉障碍的患病率和病理生理学。
Front Public Health. 2022 Jun 6;10:839182. doi: 10.3389/fpubh.2022.839182. eCollection 2022.
6
Odorant Metabolism in Humans.人类气味代谢。
Angew Chem Int Ed Engl. 2022 Aug 26;61(35):e202202866. doi: 10.1002/anie.202202866. Epub 2022 Jul 28.
7
Olfactory Dysfunction in COVID-19 Patients Who Do Not Report Olfactory Symptoms: A Pilot Study with Some Suggestions for Dentists.新冠患者嗅觉障碍但无嗅觉症状：一项针对牙医的初步研究及建议
Int J Environ Res Public Health. 2022 Jan 18;19(3):1036. doi: 10.3390/ijerph19031036.
8
Olfactory and gustatory disorders caused by COVID-19: How to regain the pleasure of eating?新冠病毒引发的嗅觉和味觉障碍：如何重拾进食的乐趣？
Trends Food Sci Technol. 2022 Apr;122:104-109. doi: 10.1016/j.tifs.2022.01.022. Epub 2022 Jan 13.
9
Potential pharmacologic treatments for COVID-19 smell and taste loss: A comprehensive review.用于治疗 COVID-19 嗅觉和味觉丧失的潜在药物治疗方法：全面综述。
Eur J Pharmacol. 2021 Dec 5;912:174582. doi: 10.1016/j.ejphar.2021.174582. Epub 2021 Oct 19.
严重 COVID-19 的主要遗传风险因素来自尼安德特人。
Nature. 2020 Nov;587(7835):610-612. doi: 10.1038/s41586-020-2818-3. Epub 2020 Sep 30.
4
Chemosensory Dysfunction in COVID-19: Integration of Genetic and Epidemiological Data Points to D614G Spike Protein Variant as a Contributing Factor.新冠病毒感染相关的嗅觉味觉障碍：遗传与流行病学数据的整合提示 D614G 棘突蛋白变异可能是致病因素之一。
ACS Chem Neurosci. 2020 Oct 21;11(20):3180-3184. doi: 10.1021/acschemneuro.0c00596. Epub 2020 Sep 30.
5
Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia.SARS-CoV-2 进入基因在嗅觉系统中的非神经元表达提示了 COVID-19 相关嗅觉丧失的潜在机制。
Sci Adv. 2020 Jul 31;6(31). doi: 10.1126/sciadv.abc5801. Epub 2020 Jul 24.
6
Important Pharmacogenetic Information for Drugs Prescribed During the SARS-CoV-2 Infection (COVID-19).治疗 SARS-CoV-2 感染（COVID-19）期间开具的药物的重要药物遗传学信息。
Clin Transl Sci. 2020 Nov;13(6):1023-1033. doi: 10.1111/cts.12866. Epub 2020 Sep 16.
7
Anosmia in COVID-19: Underlying Mechanisms and Assessment of an Olfactory Route to Brain Infection.新冠病毒感染导致的嗅觉丧失：潜在机制及经嗅觉途径感染大脑的评估
Neuroscientist. 2021 Dec;27(6):582-603. doi: 10.1177/1073858420956905. Epub 2020 Sep 11.
8
Prevalence of Chemosensory Dysfunction in COVID-19 Patients: A Systematic Review and Meta-analysis Reveals Significant Ethnic Differences.新冠病毒患者嗅觉和味觉功能障碍的流行率：系统评价和荟萃分析显示出显著的种族差异。
ACS Chem Neurosci. 2020 Oct 7;11(19):2944-2961. doi: 10.1021/acschemneuro.0c00460. Epub 2020 Sep 17.
9
Pharmacogenomics of COVID-19 therapies.新型冠状病毒肺炎治疗的药物基因组学
NPJ Genom Med. 2020 Aug 18;5:35. doi: 10.1038/s41525-020-00143-y. eCollection 2020.
10
Elevated ACE-2 expression in the olfactory neuroepithelium: implications for anosmia and upper respiratory SARS-CoV-2 entry and replication.嗅神经上皮中 ACE-2 表达升高：与嗅觉丧失以及上呼吸道 SARS-CoV-2 进入和复制有关。
Eur Respir J. 2020 Sep 24;56(3). doi: 10.1183/13993003.01948-2020. Print 2020 Sep.